dacarbazine has been researched along with Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Heimberger, A; McCoy, L; Patil, C; Patoka, J; Prados, M; Rice, T; Sampson, JH; Schwartzbaum, J; Wiemels, JL; Wiencke, JK; Wilson, D; Wrensch, M | 1 |
| Bracci, PM; McCoy, LS; Patoka, JS; Rice, T; Sison, JD; Wiemels, JL; Wiencke, JK; Wrensch, MR; Zhou, M | 1 |
2 other study(ies) available for dacarbazine and Hypersensitivity
| Article | Year |
|---|---|
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Case-Control Studies; Confounding Factors, Epidemiologic; Dacarbazine; Female; Glioma; Humans; Hypersensitivity; Immunoglobulin E; Immunotherapy; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Risk Assessment; Risk Factors; San Francisco; Surveys and Questionnaires; Temozolomide | 2009 |
Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma.
Topics: Adult; Case-Control Studies; Dacarbazine; Dexamethasone; Female; Glioma; Humans; Hypersensitivity; Immune Tolerance; Immunity, Humoral; Immunity, Innate; Immunoglobulin E; Lipopolysaccharide Receptors; Male; Middle Aged; Receptors, IgE; Temozolomide; Young Adult | 2010 |